Please login to the form below

Not currently logged in
Email:
Password:

Edelman wins AZ oncology porfolio

Edelman has won AstraZeneca's entire oncology portfolio, including Casodex and Zoladex.

The PR agency won the business against short-listed agency Cohn & Wolfe. Industry sources suggest the account could be worth up to £500,000. Edelman has previously worked on rival pharma firm Pfizer's oncology business.

The win follows AstraZeneca's decision to consolidate its oncology portfolio within one agency. The company had been using Axon Communications, Porter Novelli, Virgo Health PR and Cohn & Wolfe for individual cancer products. The latest additions to its cancer product range are Faslodex and Iressa.

AstraZeneca's head of communications, global marketing, Louise Fairburn said: "We have a number of PR directors working on the portfolio, and over time we have had a number of PR agencies, which didn't make sense."

She added: "We have a strong brand focus but not for the portfolio as a whole. This is an attempt to build a really strong global alliance in communications."

Edelman European health practice chair, Carolyn Paul, will head up the account. Fairburn will be the main point of contact for the agency.

Virgo will continue to handle the global support for Faslodex and Arimidex until quarter two next year when the accounts will be transferred to Edelman.

9th November 2009

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics